Herbs Group Keeps Share Capital and Float Steady in September 2026 Monthly Return

Bulletin Express
Oct 05

Herbs Generation Group Holdings Limited (“Herbs Group”) filed its Monthly Return with Hong Kong Exchanges and Clearing Limited for the period ended 30 September 2026, confirming a stable capital structure and full compliance with public-float rules.

Authorised Share Capital • Authorised share capital stayed unchanged at 2.00 billion ordinary shares with a par value of HKD 0.01 each, representing total authorised capital of HKD 20.00 million.

Issued and Treasury Shares • Issued shares (excluding treasury shares) were unchanged at 133.33 million. • The company held no treasury shares during the month, and no repurchases or cancellations were recorded.

Capital-Raising Instruments • No activity was reported under share option schemes, warrants, or convertible securities. • The Post-IPO Share Award Scheme, approved on 3 December 2024, did not result in any new share issuances or treasury-share transfers in September, though the mandate remains available for future allotments.

Public Float Compliance • Herbs Group confirmed that at least 25% of its issued share capital remained in public hands, meeting Main Board Rule 13.32B requirements.

Corporate Governance • The filing, signed by Company Secretary Tsang Hing Suen on 5 October 2026, affirms that all statutory and listing-rule obligations related to share capital matters were duly observed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10